Veena Devi Singh, Vijay Kumar Singh, Sanjay J Daharwal
email@example.com , firstname.lastname@example.org
Veena Devi Singh1*, Vijay Kumar Singh2 , Sanjay J Daharwal3
1Assistant Professor, Pharmacy Institute, Noida Institute of Engineering and Technology, Greater Noida, Uttar Pradesh, India- 201306.
2Associate Professor, School of Medical and Allied Sciences, Galgotias University, Greater Noida, Uttar Pradesh, India.
3Associate Professor, University Institute of Pharmacy, Pt. Ravishankar Shukla University, Raipur, Chhattisgarh, India -492010.
Volume - 14,
Issue - 10,
Year - 2021
New HPTLC method was developed and optimized for estimation of Ondansetron (OND), Dexamethasone (DEX) and Aprepitant (APT) in laboratory prepared ternary mixtures by using Central composite design (CCD). The independent variables used for the optimization were the acetone content in mobile phase (%mL), distance of developing solvent (cm) and saturation time (min). HPTLC Separation was performed on Precoated silica gel F254 aluminum plate (10X10 cm, 100µm thickness) with a mobile phase consisting of chloroform: methanol: acetone: ethyl acetate: ammonia (9:4:2:5:0.2 % v/v/v/v). Quantification of OND, APT and DEX were achieved based on a Densitometric analysis over the concentration range of 200-1200 ng/band, 500-1000 ng/band and 1000-2000 ng/band, respectively, at 254nm. The method was yielded dense and well-resolved bands at Rf values of 0.54± 0.02, 0.79±0.02 and 0.23±0.01 for OND, APT and DEX, respectively. The linear regression analysis for the calibration plots produced r2= 0.9997, r2= 0.9998 and r2=0.9997 for OND, APT and DEX, respectively. The method was validated according to the ICH guidelines. The robustness test was determined that the selected factors have an insignificant effect on the responses. The results indicated that the method is suitable for the routine quality control testing of OND, APT and DEX in their bulk form.
Cite this article:
Veena Devi Singh, Vijay Kumar Singh, Sanjay J Daharwal. Application of Central Composite Design for screening and Optimization of HPTLC method for simultaneous quantitation of Aprepitant, Dexamethasone and Ondansetron in their synthetic mixtures. Research Journal of Pharmacy and Technology 2021; 14(10):5531-9. doi: 10.52711/0974-360X.2021.00965
Veena Devi Singh, Vijay Kumar Singh, Sanjay J Daharwal. Application of Central Composite Design for screening and Optimization of HPTLC method for simultaneous quantitation of Aprepitant, Dexamethasone and Ondansetron in their synthetic mixtures. Research Journal of Pharmacy and Technology 2021; 14(10):5531-9. doi: 10.52711/0974-360X.2021.00965 Available on: https://rjptonline.org/AbstractView.aspx?PID=2021-14-10-83
1. Antiemesis, National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology, available at www.nccn.org/professionals/physician_ gls/f_guidelines. asp, Version 3. 2011.
2. Campos D et al., Prevention of cisplatin-induced emesis by the oral neurokinin-1 antagonist, MK-869, in combination with granisetron and dexamethasone or with dexamethasone alone. J Clin Oncol. 2001; 19:1759-67, https://doi.org/10.1200/JCO.2001.19.6.1759.
3. United State Pharmacopeia. United State Pharmacopeial Convention. Inc., Rockville MD: 2005, p.451-452.
4. Indian Pharmacopeia. The Controller Publication. Govt. of India, Vol. III. New Delhi: 2010, p.1201-1202.
5. Maryadele Neil JO. The Merck Index: An Encyclopedia of Chemicals, Drugs and Biologicals. 14th ed. New Jersey: Division of Merck and Co. Inc. Whitehouse station; 2006, p. 523.
6. Sweetman SC. In Martindale: The Complete Drug Reference. 35th ed. London: Pharmaceutical Press; 2007, p. 237.
7. Indian Pharmacopoeia. The Indian Pharmacopoeia Commission Ghaziabad, Govt. of India Ministry of Health and Family Welfare, vol. II; 2010, p.1175-1176.
8. Sorbera LA, Castaner J, Bayes M, Silvestre J. Aprepitant and L-758298 - Antiemetic - Antidepressant - Tachykinin Nk(1) antagonist. Drug Future 2002; 27: 211-222. https://doi.org/10.1358/dof.2002.027.03.661047
9. Morrow GR, Hesketh PJ, Schwartzberg LS, Ettinger DS. Recent Advances in the Management of Chemotherapy-induced Nausea and Vomiting: A Case Study Compendium. Clin Adv Hematol Oncol. 2010; 8:1-16.
10. Depot M, Leroux S, Caillé G. High-resolution liquid chromatographic method using ultraviolet detection for determination of ondansetron in human plasma. J Chromatogr B Biomed Sci Appl. 1997; 693:399-406.
11. Sreekanth N, Babu RC, Bahlul ZA, Mukkanti K. Development and validation of a new RP-HPLC method for the determination of Aprepitant in solid dosage forms. Trop J Pharm Res. 2011; 10: 491–497.
12. Bourdon F, Lecoeur M, Odou P, Vaccher C, Foulon C. Complementarity of UV-PLS and HPLC for the simultaneous evaluation of antiemetic drugs. Talanta. 2014; 120:274–282.
13. Müller ALH, de Oliveira JA, Prestes OD, Adaime MB, Zanella R. Design of experiments and method development. In: Solid-phase extraction. Amsterdam: Elsevier; 2020. p. 589–608.
14. Chaudhari SR, Shirkhedkar AA. Application of Plackett-Burman and central composite designs for screening and optimization of factor influencing the chromatographic conditions of HPTLC method for quantification of efonidipine hydrochloride. J Anal Sci Technol. 2020; 11:48. https://doi.org/10.1186/s40543-020-00246-2